Taking a common over-the-counter pain reliever could help keep certain cancers from spreading.That’s according to a new study ...

A new study found that aspirin may help prevent some cancers from spreading by enhancing the immune system's ability to attack metastatic cells.

They found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2) – this was an unexpected finding for the scientists. TXA2 is produced by ...

The team found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). TXA2 is produced by platelets in the blood and aspirin is already known to ...

Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell suppression and reducing the frequency of metastases in mice models. This discovery suggests a ...

The study, published in Nature, found that, in mice, aspirin acted on platelets — the tiny cells that cause blood to clot — making them produce less of a clotting factor, thromboxane A2 (TXA2 ...

Also read | Aspirin can reduce risk of heart attacks, strokes in pneumonia patients: Study The study observed that aspirin prevents cancers from spreading by decreasing TXA2 and releasing T cells ...